Division of Urology, Saban Research Institute, Children's Hospital Los Angeles, University of Southern California, Los Angeles, CA 90027, USA.
Curr Urol Rep. 2012 Feb;13(1):47-54. doi: 10.1007/s11934-011-0230-0.
Much attention recently has been focused on stem cell technology as a possible alternative modality of treatment of a variety of diseases. Chronic kidney disease is a serious health problem and most chronic kidney diseases share in common the presence of interstitial and glomerular fibrosis, regardless of the underlying cause. To date there are no specific therapies aimed at treating fibrosis in the kidney. In a novel effort to address the underlying pathology in kidney disease, researchers are demonstrating that stem cell therapy can attenuate fibrosis in chronic kidney disease in animal models. This review will focus on the recent developments in stem cell research and their possible implications to treat chronic kidney disease.
最近,人们对干细胞技术给予了高度关注,将其作为治疗各种疾病的一种可行替代疗法。慢性肾病是一个严重的健康问题,大多数慢性肾病都有间质和肾小球纤维化,无论其根本原因是什么。迄今为止,还没有专门针对肾脏纤维化的治疗方法。为了从根本上解决肾脏疾病的病理问题,研究人员正在证明干细胞疗法可以在动物模型中减轻慢性肾病的纤维化。本综述将重点介绍干细胞研究的最新进展及其对治疗慢性肾病的可能影响。